{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T14:39:56Z","timestamp":1787841596212,"version":"build-2784847793"},"reference-count":211,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T00:00:00Z","timestamp":1787788800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Oncol."],"abstract":"<jats:p>Therapy resistance in gastrointestinal tumors remains a critical challenge in clinical oncology, severely compromising therapeutic efficacy and long-term patient survival. E3 ubiquitin ligases, as core enzymes involved in the protein ubiquitination process, have been demonstrated to play indispensable roles in regulating key biological processes in tumor cells, including DNA damage repair, cell cycle progression, apoptosis, cancer stem cell maintenance, and immune evasion. Additionally, E3 ligases are key regulators of resistance to multiple anticancer strategies, such as chemotherapy, radiotherapy, targeted therapy, and immunotherapy. This review systematically summarizes the functions and mechanisms of E3 ligases in DNA damage response and cancer therapy resistance, and further highlight recent advances in therapeutic approaches by targeting specific E3 ligases. Notably, combining E3 inhibitors with existing anticancer therapies may substantially enhance treatment responses and improve patient prognosis, providing a solid theoretical basis for future clinical applications.<\/jats:p>","DOI":"10.3389\/fonc.2026.1835284","type":"journal-article","created":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T14:07:36Z","timestamp":1787839656000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["E3 ubiquitin ligases orchestrate chemo-resistance in gastrointestinal malignancies: from DNA damage response to therapeutic targeting"],"prefix":"10.3389","volume":"16","author":[{"given":"Teng","family":"Ma","sequence":"first","affiliation":[{"name":"Cuiying Biomedical Research Center, Gansu Province Key Laboratory of Environmental Oncology, Lanzhou University Second Hospital","place":["Lanzhou, Gansu, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongzhu","family":"Zhou","sequence":"additional","affiliation":[{"name":"Cuiying Biomedical Research Center, Gansu Province Key Laboratory of Environmental Oncology, Lanzhou University Second Hospital","place":["Lanzhou, Gansu, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaojun","family":"Li","sequence":"additional","affiliation":[{"name":"Cuiying Biomedical Research Center, Gansu Province Key Laboratory of Environmental Oncology, Lanzhou University Second Hospital","place":["Lanzhou, Gansu, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junhong","family":"Guan","sequence":"additional","affiliation":[{"name":"Cuiying Biomedical Research Center, Gansu Province Key Laboratory of Environmental Oncology, Lanzhou University Second Hospital","place":["Lanzhou, Gansu, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,8,27]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1136\/gutjnl-2024-333227","article-title":"Epidemiology of gastrointestinal cancers: a systematic analysis from the Global Burden of Disease Study 2021","volume":"74","author":"Danpanichkul","year":"2024","journal-title":"Gut"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.2174\/0113862073296206240416060154","article-title":"Targeted drug nanodelivery and immunotherapy for combating tumor resistance","volume":"28","author":"Liu","year":"2025","journal-title":"Comb Chem High Throughput Screen"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1016\/j.drup.2024.101125","article-title":"Cellular and molecular mechanisms of gastrointestinal cancer liver metastases and drug resistance","volume":"77","author":"Dong","year":"2024","journal-title":"Drug Resist Update"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2021.119933","article-title":"Crosstalk between lncRNAs and miRNAs in gastrointestinal cancer drug resistance","volume":"284","author":"Raei","year":"2021","journal-title":"Life Sci"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2025.12.049","article-title":"Hallmarks of cancer-then and now, and beyond","author":"Hanahan","year":"2026","journal-title":"Cell"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1016\/j.molcel.2015.10.040","article-title":"Targeting the DNA damage response in cancer","volume":"60","author":"O'Connor","year":"2015","journal-title":"Mol Cell"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1038\/nature10760","article-title":"The DNA damage response and cancer therapy","volume":"481","author":"Lord","year":"2012","journal-title":"Nature"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbagrm.2023.194977","article-title":"Protein post-translational modifications: a key factor in colorectal cancer resistance mechanisms","volume":"1866","author":"Bi","year":"2023","journal-title":"Biochim Biophys Acta Gene Regul Mech"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1002\/9780470123133.ch3","article-title":"Post-translational modification of proteins","volume":"67","author":"Krishna","year":"1993","journal-title":"Adv Enzymol Relat Areas Mol Biol"},{"key":"B10","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1007\/s00432-024-05659-9","article-title":"The cross talk of ubiquitination and chemotherapy tolerance in colorectal cancer","volume":"150","author":"Rong","year":"2024","journal-title":"J Cancer Res Clin Oncol"},{"key":"B11","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1007\/s00109-020-02015-5","article-title":"Roles of E3 ubiquitin ligases in gastric cancer carcinogenesis and their effects on cisplatin resistance","volume":"99","author":"Wang","year":"2021","journal-title":"J Mol Med (Berlin Germany)"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1038\/nm.3739","article-title":"Ubiquitination in disease pathogenesis and treatment","volume":"20","author":"Popovic","year":"2014","journal-title":"Nat Med"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2016.03.003","article-title":"Types of ubiquitin ligases","volume":"165","author":"Morreale","year":"2016","journal-title":"Cell"},{"key":"B14","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1186\/s43556-021-00043-2","article-title":"E3 ubiquitin ligases: styles, structures and functions","volume":"2","author":"Yang","year":"2021","journal-title":"Mol BioMed"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.3390\/molecules26216682","article-title":"Structural diversity of ubiquitin E3 ligase","volume":"26","author":"Toma-Fukai","year":"2021","journal-title":"Molecules"},{"key":"B16","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1038\/nrc3430","article-title":"MDM2, MDMX and p53 in oncogenesis and cancer therapy","volume":"13","author":"Wade","year":"2013","journal-title":"Nat Rev Cancer"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22189795","article-title":"Loss of Von Hippel-Lindau (VHL) tumor suppressor gene function: VHL-HIF pathway and advances in treatments for metastatic renal cell carcinoma (RCC)","volume":"22","author":"Kim","year":"2021","journal-title":"Int J Mol Sci"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1016\/j.tibs.2025.07.009","article-title":"E3 ubiquitin ligases in signaling, disease, and therapeutics","volume":"50","author":"Ebadi","year":"2025","journal-title":"Trends Biochem Sci"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1007\/s12013-024-01223-x","article-title":"E3 ubiquitin ligase ASB14 inhibits cardiomyocyte proliferation by regulating MAPRE2 ubiquitination","volume":"82","author":"Yang","year":"2024","journal-title":"Cell Biochem Biophys"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1038\/nature08467","article-title":"The DNA-damage response in human biology and disease","volume":"461","author":"Jackson","year":"2009","journal-title":"Nature"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1016\/j.dnarep.2009.01.013","article-title":"Regulatory ubiquitylation in response to DNA double-strand breaks","volume":"8","author":"Panier","year":"2009","journal-title":"DNA Repair (Amst)"},{"key":"B22","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1038\/nrc.2017.105","article-title":"Ubiquitin ligases in oncogenic transformation and cancer therapy","volume":"18","author":"Senft","year":"2018","journal-title":"Nat Rev Cancer"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1016\/j.molcel.2006.01.020","article-title":"p53 ubiquitination: Mdm2 and beyond","volume":"21","author":"Brooks","year":"2006","journal-title":"Mol Cell"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1126\/science.1244851","article-title":"Lenalidomide causes selective degradation of IKZF1 and IKZF3 in multiple myeloma cells","volume":"343","author":"Kronke","year":"2014","journal-title":"Science"},{"key":"B25","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1038\/s41392-022-00999-9","article-title":"PROTACs: great opportunities for academia and industry (an update from 2020 to 2021)","volume":"7","author":"He","year":"2022","journal-title":"Signal Transduct Target Ther"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1016\/j.molcel.2007.11.015","article-title":"The DNA damage response: ten years after","volume":"28","author":"Harper","year":"2007","journal-title":"Mol Cell"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1016\/j.dnarep.2010.09.011","article-title":"The ubiquitous role of ubiquitin in the DNA damage response","volume":"9","author":"Al-Hakim","year":"2010","journal-title":"DNA Repair (Amst)"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1042\/BCJ20240124","article-title":"E3 ligases: a ubiquitous link between DNA repair, DNA replication and human disease","volume":"481","author":"Chauhan","year":"2024","journal-title":"Biochem J"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1186\/s13578-020-0376-x","article-title":"ATM, ATR and DNA-PKcs kinases-the lessons from the mouse models: inhibition not equal deletion","volume":"10","author":"Menolfi","year":"2020","journal-title":"Cell Biosci"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.3390\/biom5042877","article-title":"ATM-dependent phosphorylation of all three members of the MRN complex: from sensor to adaptor","volume":"5","author":"Lavin","year":"2015","journal-title":"Biomolecules"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1038\/nrc2723","article-title":"The first 30 years of p53: growing ever more complex","volume":"9","author":"Levine","year":"2009","journal-title":"Nat Rev Cancer"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1007856107","article-title":"Reconstitution of RPA-covered single-stranded DNA-activated ATR-Chk1 signaling","volume":"107","author":"Choi","year":"2010","journal-title":"Proc Natl Acad Sci USA"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.28226","article-title":"Roles of Chk1 in cell biology and cancer therapy","volume":"134","author":"Zhang","year":"2013","journal-title":"Int J Cancer"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1101\/gad.886901","article-title":"ATM-dependent phosphorylation of Mdm2 on serine 395: role in p53 activation by DNA damage","volume":"15","author":"Maya","year":"2001","journal-title":"Genes Dev"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1038\/emboj.2009.294","article-title":"ATM activates p53 by regulating MDM2 oligomerization and E3 processivity","volume":"28","author":"Cheng","year":"2009","journal-title":"EMBO J"},{"key":"B36","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1016\/j.cell.2012.06.039","article-title":"TRIP12 and UBR5 suppress spreading of chromatin ubiquitylation at damaged chromosomes","volume":"150","author":"Gudjonsson","year":"2012","journal-title":"Cell"},{"key":"B37","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1158\/2159-8290.CD-21-1059","article-title":"Hallmarks of cancer: new dimensions","volume":"12","author":"Hanahan","year":"2022","journal-title":"Cancer Discov"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.3390\/ijms14036359","article-title":"Ubiquitinations in the notch signaling pathway","volume":"14","author":"Moretti","year":"2013","journal-title":"Int J Mol Sci"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1038\/cr.2016.40","article-title":"Ubiquitin signaling in immune responses","volume":"26","author":"Hu","year":"2016","journal-title":"Cell Res"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1038\/nrd3626","article-title":"The secret ally: immunostimulation by anticancer drugs","volume":"11","author":"Galluzzi","year":"2012","journal-title":"Nat Rev Drug Discov"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccell.2016.10.010","article-title":"Deubiquitination and stabilization of PD-L1 by CSN5","volume":"30","author":"Lim","year":"2016","journal-title":"Cancer Cell"},{"key":"B42","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/j.ccell.2018.01.009","article-title":"Eradication of triple-negative breast cancer cells by targeting glycosylated PD-L1","volume":"33","author":"Li","year":"2018","journal-title":"Cancer Cell"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms12632","article-title":"Glycosylation and stabilization of programmed death ligand-1 suppresses T-cell activity","volume":"7","author":"Li","year":"2016","journal-title":"Nat Commun"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1158\/2159-8290.CD-18-1020","article-title":"Targeting DNA damage response promotes antitumor immunity through STING-mediated T-cell activation in small cell lung cancer","volume":"9","author":"Sen","year":"2019","journal-title":"Cancer Discov"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2006.11.039","article-title":"NEDD4-1 is a proto-oncogenic ubiquitin ligase for PTEN","volume":"128","author":"Wang","year":"2007","journal-title":"Cell"},{"key":"B46","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1016\/j.cell.2017.04.001","article-title":"AKT\/PKB signaling: navigating the network","volume":"169","author":"Manning","year":"2017","journal-title":"Cell"},{"key":"B47","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/j.dnarep.2017.06.011","article-title":"Histone ubiquitination in the DNA damage response","volume":"56","author":"Uckelmann","year":"2017","journal-title":"DNA Repair (Amst)"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1038\/s41580-018-0003-4","article-title":"Mechanism and medical implications of mammalian autophagy","volume":"19","author":"Dikic","year":"2018","journal-title":"Nat Rev Mol Cell Biol"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1172\/JCI73941","article-title":"The role for autophagy in cancer","volume":"125","author":"White","year":"2015","journal-title":"J Clin Invest"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuron.2014.12.007","article-title":"The roles of PINK1, parkin, and mitochondrial fidelity in Parkinson's disease","volume":"85","author":"Pickrell","year":"2015","journal-title":"Neuron"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.31335","article-title":"Targeting autophagy in cancer","volume":"124","author":"Onorati","year":"2018","journal-title":"Cancer"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1007\/s13402-023-00777-x","article-title":"E3 ubiquitin ligases in cancer stem cells: key regulators of cancer hallmarks and novel therapeutic opportunities","volume":"46","author":"Zou","year":"2023","journal-title":"Cell Oncol (Dordr)"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1038\/nm.4409","article-title":"Cancer stem cells revisited","volume":"23","author":"Batlle","year":"2017","journal-title":"Nat Med"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1038\/nrclinonc.2015.61","article-title":"Targeting Notch, Hedgehog, and Wnt pathways in cancer stem cells: clinical update","volume":"12","author":"Takebe","year":"2015","journal-title":"Nat Rev Clin Oncol"},{"key":"B55","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1038\/nrc2290","article-title":"FBW7 ubiquitin ligase: a tumour suppressor at the crossroads of cell division, growth and differentiation","volume":"8","author":"Welcker","year":"2008","journal-title":"Nat Rev Cancer"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1038\/bjc.2014.259","article-title":"Role of Fbxw7 in the maintenance of normal stem cells and cancer-initiating cells","volume":"111","author":"Takeishi","year":"2014","journal-title":"Br J Cancer"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1038\/nature11308","article-title":"Tumour suppressor RNF43 is a stem-cell E3 ligase that induces endocytosis of Wnt receptors","volume":"488","author":"Koo","year":"2012","journal-title":"Nature"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.3390\/cancers14040990","article-title":"Protein degradation by E3 ubiquitin ligases in cancer stem cells","volume":"14","author":"Quiroga","year":"2022","journal-title":"Cancers (Basel)"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2010.05.078","article-title":"F-box and WD repeat domain-containing 7 regulates intestinal cell lineage commitment and is a haploinsufficient tumor suppressor","volume":"139","author":"Sancho","year":"2010","journal-title":"Gastroenterology"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.24879","article-title":"Loss of FBXW7, a cell cycle regulating gene, in colorectal cancer: clinical significance","volume":"126","author":"Iwatsuki","year":"2010","journal-title":"Int J Cancer"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-biochem-060310-170328","article-title":"The ubiquitin code","volume":"81","author":"Komander","year":"2012","journal-title":"Annu Rev Biochem"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.1016\/j.molcel.2009.01.014","article-title":"Nonproteolytic functions of ubiquitin in cell signaling","volume":"33","author":"Chen","year":"2009","journal-title":"Mol Cell"},{"key":"B63","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1038\/cdd.2009.68","article-title":"Mdm2-mediated ubiquitylation: p53 and beyond","volume":"17","author":"Marine","year":"2010","journal-title":"Cell Death Differ"},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2008.12.042","article-title":"The RIDDLE syndrome protein mediates a ubiquitin-dependent signaling cascade at sites of DNA damage","volume":"136","author":"Stewart","year":"2009","journal-title":"Cell"},{"key":"B65","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1016\/j.cell.2007.09.040","article-title":"RNF8 ubiquitylates histones at DNA double-strand breaks and promotes assembly of repair proteins","volume":"131","author":"Mailand","year":"2007","journal-title":"Cell"},{"key":"B66","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1016\/j.molcel.2013.01.017","article-title":"Regulation of DNA damage responses by ubiquitin and SUMO","volume":"49","author":"Jackson","year":"2013","journal-title":"Mol Cell"},{"key":"B67","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1038\/nrm3719","article-title":"Double-strand break repair: 53BP1 comes into focus","volume":"15","author":"Panier","year":"2014","journal-title":"Nat Rev Mol Cell Biol"},{"key":"B68","doi-asserted-by":"publisher","DOI":"10.1038\/nrm.2016.58","article-title":"Regulation of DNA double-strand break repair by ubiquitin and ubiquitin-like modifiers","volume":"17","author":"Schwertman","year":"2016","journal-title":"Nat Rev Mol Cell Biol"},{"key":"B69","doi-asserted-by":"publisher","DOI":"10.1101\/gad.189274.112","article-title":"SUMO-targeted ubiquitin E3 ligase RNF4 is required for the response of human cells to DNA damage","volume":"26","author":"Yin","year":"2012","journal-title":"Genes Dev"},{"key":"B70","doi-asserted-by":"publisher","DOI":"10.1038\/nrc3916","article-title":"Replication stress and cancer","volume":"15","author":"Gaillard","year":"2015","journal-title":"Nat Rev Cancer"},{"key":"B71","doi-asserted-by":"publisher","DOI":"10.1038\/nrm2852","article-title":"Maintaining genome stability at the replication fork","volume":"11","author":"Branzei","year":"2010","journal-title":"Nat Rev Mol Cell Biol"},{"key":"B72","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2008.12.041","article-title":"RNF168 binds and amplifies ubiquitin conjugates on damaged chromosomes to allow accumulation of repair proteins","volume":"136","author":"Doil","year":"2009","journal-title":"Cell"},{"key":"B73","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1146\/annurev.biochem.78.101807.093809","article-title":"RING domain E3 ubiquitin ligases","volume":"78","author":"Deshaies","year":"2009","journal-title":"Annu Rev Biochem"},{"key":"B74","doi-asserted-by":"publisher","DOI":"10.1111\/j.1749-6632.1993.tb32280.x","article-title":"The RING finger. A novel protein sequence motif related to the zinc finger","volume":"684","author":"Freemont","year":"1993","journal-title":"Ann N Y Acad Sci"},{"key":"B75","doi-asserted-by":"publisher","DOI":"10.2174\/1568009616666151112122801","article-title":"RING-, HECT-, and RBR-type E3 ubiquitin ligases: involvement in human cancer","volume":"16","author":"Uchida","year":"2016","journal-title":"Curr Cancer Drug Targets"},{"key":"B76","doi-asserted-by":"publisher","DOI":"10.1016\/j.biochi.2015.08.003","article-title":"Cullin 5-RING E3 ubiquitin ligases, new therapeutic targets","volume":"122","author":"Lamsoul","year":"2016","journal-title":"Biochimie"},{"key":"B77","doi-asserted-by":"publisher","first-page":"3679","DOI":"10.1016\/j.molcel.2023.09.015","article-title":"Crucial roles of the BRCA1-BARD1 E3 ubiquitin ligase activity in homology-directed DNA repair","volume":"83","author":"Wang","year":"2023","journal-title":"Mol Cell"},{"key":"B78","doi-asserted-by":"publisher","DOI":"10.1038\/35056563","article-title":"Themes and variations on ubiquitylation","volume":"2","author":"Weissman","year":"2001","journal-title":"Nat Rev Mol Cell Biol"},{"key":"B79","doi-asserted-by":"publisher","DOI":"10.7150\/thno.78876","article-title":"Targeting cullin neddylation for cancer and fibrotic diseases","volume":"13","author":"He","year":"2023","journal-title":"Theranostics"},{"key":"B80","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/j.semcancer.2020.03.001","article-title":"APC\/C ubiquitin ligase: Functions and mechanisms in tumorigenesis","volume":"67","author":"Schrock","year":"2020","journal-title":"Semin Cancer Biol"},{"key":"B81","doi-asserted-by":"publisher","DOI":"10.1016\/j.jmb.2017.08.008","article-title":"RING-between-RING E3 ligases: emerging themes amid the variations","volume":"429","author":"Dove","year":"2017","journal-title":"J Mol Biol"},{"key":"B82","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.bbamcr.2013.05.026","article-title":"RING-type E3 ligases: master manipulators of E2 ubiquitin-conjugating enzymes and ubiquitination","volume":"1843","author":"Metzger","year":"2014","journal-title":"Biochim Biophys Acta"},{"key":"B83","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-biochem-060815-014922","article-title":"Ubiquitin ligases: structure, function, and regulation","volume":"86","author":"Zheng","year":"2017","journal-title":"Annu Rev Biochem"},{"key":"B84","doi-asserted-by":"publisher","DOI":"10.1593\/neo.06469","article-title":"Novel RING E3 ubiquitin ligases in breast cancer","volume":"8","author":"Burger","year":"2006","journal-title":"Neoplasia (New York NY)"},{"key":"B85","doi-asserted-by":"publisher","DOI":"10.1042\/bst20201060","article-title":"Recent insight into the role of RING-finger E3 ligases in glioma","volume":"49","author":"Cao","year":"2021","journal-title":"Biochem Soc Trans"},{"key":"B86","doi-asserted-by":"publisher","DOI":"10.1038\/onc.2017.313","article-title":"Functional significance and therapeutic implication of ring-type E3 ligases in colorectal cancer","volume":"37","author":"Liu","year":"2018","journal-title":"Oncogene"},{"key":"B87","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1038\/s41419-024-06783-7","article-title":"Canonical and non-canonical functions of p53 isoforms: potentiating the complexity of tumor development and therapy resistance","volume":"15","author":"Guo","year":"2024","journal-title":"Cell Death Dis"},{"key":"B88","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1186\/s11658-021-00293-6","article-title":"Resistance mechanisms to inhibitors of p53-MDM2 interactions in cancer therapy: can we overcome them","volume":"26","author":"Haronikova","year":"2021","journal-title":"Cell Mol Biol Lett"},{"key":"B89","doi-asserted-by":"publisher","DOI":"10.2174\/0929867323666160926150820","article-title":"MDM2 increases drug resistance in cancer cells by inducing EMT independent of p53","volume":"23","author":"Sun","year":"2016","journal-title":"Curr Med Chem"},{"key":"B90","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2022.971162","article-title":"Negative regulation of receptor tyrosine kinases by ubiquitination: Key roles of the Cbl family of E3 ubiquitin ligases","volume":"13","author":"Tang","year":"2022","journal-title":"Front Endocrinol"},{"key":"B91","doi-asserted-by":"publisher","DOI":"10.1002\/1878-0261.12140","article-title":"DR5-Cbl-b\/c-Cbl-TRAF2 complex inhibits TRAIL-induced apoptosis by promoting TRAF2-mediated polyubiquitination of caspase-8 in gastric cancer cells","volume":"11","author":"Xu","year":"2017","journal-title":"Mol Oncol"},{"key":"B92","doi-asserted-by":"publisher","DOI":"10.15283\/ijsc23070","article-title":"RNF43 and ZNRF3 in Wnt signaling - A master regulator at the membrane","volume":"16","author":"Farnhammer","year":"2023","journal-title":"Int J Stem Cells"},{"key":"B93","doi-asserted-by":"publisher","DOI":"10.1101\/gad.235473.113","article-title":"The R-spondin\/Lgr5\/Rnf43 module: regulator of Wnt signal strength","volume":"28","author":"De la Lau","year":"2014","journal-title":"Genes Dev"},{"key":"B94","doi-asserted-by":"publisher","DOI":"10.1016\/j.tibs.2019.08.004","article-title":"HECT-type E3 ubiquitin ligases in cancer","volume":"44","author":"Bernassola","year":"2019","journal-title":"Trends Biochem Sci"},{"key":"B95","doi-asserted-by":"publisher","DOI":"10.3389\/fphys.2019.00370","article-title":"HECT E3 ligases: A tale with multiple facets","volume":"10","author":"Weber","year":"2019","journal-title":"Front Physiol"},{"key":"B96","doi-asserted-by":"publisher","DOI":"10.2478\/jtim-2020-0012","article-title":"Structure and function of HECT E3 ubiquitin ligases and their role in oxidative stress","volume":"8","author":"Qian","year":"2020","journal-title":"J Trans Internal Med"},{"key":"B97","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.semcancer.2021.06.012","article-title":"The HECT family of E3 ubiquitin ligases and PTEN","volume":"85","author":"Song","year":"2022","journal-title":"Semin Cancer Biol"},{"key":"B98","doi-asserted-by":"publisher","first-page":"2603","DOI":"10.1016\/j.cell.2025.03.001","article-title":"Therapeutic potential of allosteric HECT E3 ligase inhibition","volume":"188","author":"Rothman","year":"2025","journal-title":"Cell"},{"key":"B99","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1186\/s10020-023-00628-3","article-title":"The role of NEDD4 related HECT-type E3 ubiquitin ligases in defective autophagy in cancer cells: molecular mechanisms and therapeutic perspectives","volume":"29","author":"Zhang","year":"2023","journal-title":"Mol Med (Cambridge Mass)"},{"key":"B100","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.RA119.009211","article-title":"Comparative analysis of the catalytic regulation of NEDD4-1 and WWP2 ubiquitin ligases","volume":"294","author":"Jiang","year":"2019","journal-title":"J Biol Chem"},{"key":"B101","doi-asserted-by":"publisher","DOI":"10.1016\/j.apsb.2023.05.017","article-title":"Pharmacological inhibition of BAP1 recruits HERC2 to competitively dissociate BRCA1-BARD1, suppresses DNA repair and sensitizes CRC to radiotherapy","volume":"13","author":"Yue","year":"2023","journal-title":"Acta Pharm Sin B"},{"key":"B102","doi-asserted-by":"publisher","DOI":"10.1080\/09687860600665010","article-title":"Regulation of the nuclear localization of the human Nedd4-related WWP1 protein by Notch","volume":"23","author":"Flasza","year":"2006","journal-title":"Mol Membr Biol"},{"key":"B103","doi-asserted-by":"publisher","DOI":"10.1242\/jcs.228072","article-title":"HECT E3 ubiquitin ligases - emerging insights into their biological roles and disease relevance","volume":"133","author":"Wang","year":"2020","journal-title":"J Cell Sci"},{"key":"B104","doi-asserted-by":"publisher","DOI":"10.1016\/j.semcancer.2020.05.002","article-title":"RBR E3 ubiquitin ligases in tumorigenesis","volume":"67","author":"Wang","year":"2020","journal-title":"Semin Cancer Biol"},{"key":"B105","doi-asserted-by":"publisher","DOI":"10.1042\/bst20200237","article-title":"Chain reactions: molecular mechanisms of RBR ubiquitin ligases","volume":"48","author":"Cotton","year":"2020","journal-title":"Biochem Soc Trans"},{"key":"B106","doi-asserted-by":"publisher","DOI":"10.1002\/embr.201338166","article-title":"RBR E3-ligases at work","volume":"15","author":"Smit","year":"2014","journal-title":"EMBO Rep"},{"key":"B107","doi-asserted-by":"publisher","DOI":"10.1128\/mcb.01152-14","article-title":"The E3 ubiquitin ligase ARIH1 protects against genotoxic stress by initiating a 4EHP-mediated mRNA translation arrest","volume":"35","author":"Von Stechow","year":"2015","journal-title":"Mol Cell Biol"},{"key":"B108","doi-asserted-by":"publisher","DOI":"10.1016\/j.xcrm.2022.100655","article-title":"RNF31 inhibition sensitizes tumors to bystander killing by innate and adaptive immune cells","volume":"3","author":"Zhang","year":"2022","journal-title":"Cell Rep Med"},{"key":"B109","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1186\/s13046-024-03045-4","article-title":"The TP53-activated E3 ligase RNF144B is a tumour suppressor that prevents genomic instability","volume":"43","author":"Abad","year":"2024","journal-title":"J Exp Clin Cancer Res CR"},{"key":"B110","doi-asserted-by":"publisher","DOI":"10.3390\/cancers13040745","article-title":"Regulation of p53 by E3s","volume":"13","author":"Pan","year":"2021","journal-title":"Cancers"},{"key":"B111","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1038\/s41419-022-04965-9","article-title":"ARIH2 regulates the proliferation, DNA damage and chemosensitivity of gastric cancer cells by reducing the stability of p21 via ubiquitination","volume":"13","author":"Geng","year":"2022","journal-title":"Cell Death Dis"},{"key":"B112","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M111.314765","article-title":"Calpain-mediated processing of p53-associated parkin-like cytoplasmic protein (PARC) affects chemosensitivity of human ovarian cancer cells by promoting p53 subcellular trafficking","volume":"287","author":"Woo","year":"2012","journal-title":"J Biol Chem"},{"key":"B113","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1483721","article-title":"Role and therapeutic potential of E3s in the tumor microenvironment of hepatocellular carcinoma","volume":"15","author":"Wang","year":"2024","journal-title":"Front Immunol"},{"key":"B114","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202501017","article-title":"The E3 ubiquitin ligase ARIH1 facilitates colorectal cancer progression by promoting oxidative phosphorylation via the mitochondrial translocation of K63-linked ubiquitinated PHB1","volume":"12","author":"Tong","year":"2025","journal-title":"Adv Sci (Weinh)"},{"key":"B115","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2014.07.025","article-title":"Cisplatin in cancer therapy: molecular mechanisms of action","volume":"740","author":"Dasari","year":"2014","journal-title":"Eur J Pharmacol"},{"key":"B116","doi-asserted-by":"publisher","DOI":"10.1038\/onc.2011.384","article-title":"Molecular mechanisms of cisplatin resistance","volume":"31","author":"Galluzzi","year":"2012","journal-title":"Oncogene"},{"key":"B117","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1038\/s41420-023-01478-y","article-title":"hMOF induces cisplatin resistance of ovarian cancer by regulating the stability and expression of MDM2","volume":"9","author":"Cai","year":"2023","journal-title":"Cell Death Discov"},{"key":"B118","doi-asserted-by":"publisher","DOI":"10.1038\/sj.onc.1211032","article-title":"A novel HECT-type E3 ubiquitin protein ligase NEDL1 enhances the p53-mediated apoptotic cell death in its catalytic activity-independent manner","volume":"27","author":"Li","year":"2008","journal-title":"Oncogene"},{"key":"B119","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1038\/s42003-023-05166-6","article-title":"Skp2-mediated MLKL degradation confers cisplatin-resistant in non-small cell lung cancer cells","volume":"6","author":"Zhou","year":"2023","journal-title":"Commun Biol"},{"key":"B120","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcp.2025.116903","article-title":"N6-methyladenosine-modified RNF220 induces cisplatin resistance and immune escape via regulating PDE10A K48-linked ubiquitination in bladder cancer","volume":"236","author":"Li","year":"2025","journal-title":"Biochem Pharmacol"},{"key":"B121","doi-asserted-by":"publisher","DOI":"10.1002\/1878-0261.70089","article-title":"\u03b2-TrCP overexpression enhances cisplatin sensitivity by depleting BRCA1","author":"Jim\u00e9nez-Guerrero","year":"2025","journal-title":"Mol Oncol"},{"key":"B122","doi-asserted-by":"publisher","DOI":"10.3389\/fphys.2022.968927","article-title":"The regulatory roles of the E3 ubiquitin ligase NEDD4 family in DNA damage response","volume":"13","author":"Lu","year":"2022","journal-title":"Front Physiol"},{"key":"B123","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2020.607060","article-title":"The E3 ubiquitin ligase NEDD4L targets OGG1 for ubiquitylation and modulates the cellular DNA damage response","volume":"8","author":"Hughes","year":"2020","journal-title":"Front Cell Dev Biol"},{"key":"B124","doi-asserted-by":"publisher","DOI":"10.1080\/15384101.2017.1308617","article-title":"NEDD4 is involved in acquisition of epithelial-mesenchymal transition in cisplatin-resistant nasopharyngeal carcinoma cells","volume":"16","author":"Feng","year":"2017","journal-title":"Cell Cycle (Georgetown Tex)"},{"key":"B125","doi-asserted-by":"publisher","DOI":"10.1038\/s41418-021-00875-z","article-title":"Inhibition of USP28 overcomes cisplatin-resistance of squamous tumors by suppression of the Fanconi anemia pathway","volume":"29","author":"Prieto-Garcia","year":"2022","journal-title":"Cell Death Differ"},{"key":"B126","doi-asserted-by":"publisher","DOI":"10.1038\/onc.2016.336","article-title":"Downregulation of the proapoptotic protein MOAP-1 by the UBR5 ubiquitin ligase and its role in ovarian cancer resistance to cisplatin","volume":"36","author":"Matsuura","year":"2017","journal-title":"Oncogene"},{"key":"B127","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1186\/s13046-021-02149-5","article-title":"CircRNA-DOPEY2 enhances the chemosensitivity of esophageal cancer cells by inhibiting CPEB4-mediated Mcl-1 translation","volume":"40","author":"Liu","year":"2021","journal-title":"J Exp Clin Cancer Res CR"},{"key":"B128","doi-asserted-by":"publisher","DOI":"10.1093\/narcan\/zcab002","article-title":"The DNA damage inducible lncRNA SCAT7 regulates genomic integrity and topoisomerase 1 turnover in lung adenocarcinoma","volume":"3","author":"Statello","year":"2021","journal-title":"NAR Cancer"},{"key":"B129","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1139\/bcb-2024-0264","article-title":"Doxorubicin, a DNA intercalator, inhibits transcription elongation","volume":"103","author":"Tempel","year":"2025"},{"key":"B130","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1186\/s13045-022-01345-w","article-title":"CircRNA-CREIT inhibits stress granule assembly and overcomes doxorubicin resistance in TNBC by destabilizing PKR","volume":"15","author":"Wang","year":"2022","journal-title":"J Hematol Oncol"},{"key":"B131","doi-asserted-by":"publisher","DOI":"10.1097\/js9.0000000000003061","article-title":"UBR5 antagonizes DNA damage to enhance the doxorubicin-resistance of triple negative breast cancer by p38 signaling","author":"Zhang","year":"2025","journal-title":"Int J Surg (London England)"},{"key":"B132","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1186\/s13046-022-02344-y","article-title":"Genome-wide CRISPR screen identified Rad18 as a determinant of doxorubicin sensitivity in osteosarcoma","volume":"41","author":"Du","year":"2022","journal-title":"J Exp Clin Cancer Res CR"},{"key":"B133","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcp.2024.116720","article-title":"E3 ubiquitin ligase ITCH-mediated proteasomal degradation of WBP2 sensitizes breast cancer cells to chemotherapy through restraining AMOTL2\/c-JUN axis","volume":"232","author":"Zhu","year":"2025","journal-title":"Biochem Pharmacol"},{"key":"B134","doi-asserted-by":"publisher","first-page":"1984","DOI":"10.21037\/gs-22-716","article-title":"WW domain binding protein 2 (WBP2) as an oncogene in breast cancer: mechanisms and therapeutic prospects-a narrative review","volume":"11","author":"Liu","year":"2022","journal-title":"Gland Surg"},{"key":"B135","doi-asserted-by":"publisher","DOI":"10.1091\/mbc.E14-04-0916","article-title":"How Taxol\/paclitaxel kills cancer cells","volume":"25","author":"Weaver","year":"2014","journal-title":"Mol Biol Cell"},{"key":"B136","doi-asserted-by":"publisher","DOI":"10.1038\/s41388-022-02180-6","article-title":"Stabilization of AURKA by the E3 ubiquitin ligase CBLC in lung adenocarcinoma","volume":"41","author":"Hong","year":"2022","journal-title":"Oncogene"},{"key":"B137","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2020.105143","article-title":"Targeting stress granules: A novel therapeutic strategy for human diseases","volume":"161","author":"Wang","year":"2020","journal-title":"Pharmacol Res"},{"key":"B138","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1038\/s41419-022-04619-w","article-title":"Degradation of DRAK1 by CUL3\/SPOP E3 ubiquitin ligase promotes tumor growth of paclitaxel-resistant cervical cancer cells","volume":"13","author":"Pang","year":"2022","journal-title":"Cell Death Dis"},{"key":"B139","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.Can-19-3428","article-title":"Destablilization of TRAF6 by DRAK1 suppresses tumor growth and metastasis in cervical cancer cells","volume":"80","author":"Park","year":"2020","journal-title":"Cancer Res"},{"key":"B140","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1002\/path.2512","article-title":"Parkin regulates paclitaxel sensitivity in breast cancer via a microtubule-dependent mechanism","volume":"218","author":"Wang","year":"2009","journal-title":"J Pathol"},{"key":"B141","doi-asserted-by":"publisher","DOI":"10.1016\/j.freeradbiomed.2021.11.024","article-title":"FOXM1-mediated activation of phospholipase D1 promotes lipid droplet accumulation and reduces ROS to support paclitaxel resistance in metastatic cancer cells","volume":"179","author":"Zhang","year":"2022","journal-title":"Free Radical Biol Med"},{"key":"B142","doi-asserted-by":"publisher","DOI":"10.1126\/science.aam7344","article-title":"PARP inhibitors: Synthetic lethality in the clinic","volume":"355","author":"Lord","year":"2017","journal-title":"Science"},{"key":"B143","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1186\/s12943-020-01227-0","article-title":"PARP inhibitor resistance: the underlying mechanisms and clinical implications","volume":"19","author":"Li","year":"2020","journal-title":"Mol Cancer"},{"key":"B144","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.adg7752","article-title":"Nimbolide targets RNF114 to induce the trapping of PARP1 and synthetic lethality in BRCA-mutated cancer","volume":"9","author":"Li","year":"2023","journal-title":"Sci Adv"},{"key":"B145","doi-asserted-by":"publisher","DOI":"10.1016\/j.trecan.2021.08.007","article-title":"Tackling PARP inhibitor resistance","volume":"7","author":"Fugger","year":"2021","journal-title":"Trends Cancer"},{"key":"B146","doi-asserted-by":"publisher","DOI":"10.1136\/ijgc-2022-003698","article-title":"Overcoming PARP inhibitor resistance in ovarian cancer","volume":"33","author":"Soberanis Pina","year":"2023","journal-title":"Int J Gynecological Cancer Off J Int Gynecological Cancer Soc"},{"key":"B147","doi-asserted-by":"publisher","DOI":"10.1038\/onc.2015.198","article-title":"RNF126 promotes homologous recombination via regulation of E2F1-mediated BRCA1 expression","volume":"35","author":"Wang","year":"2016","journal-title":"Oncogene"},{"key":"B148","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbrc.2021.08.011","article-title":"CHFR-mediated degradation of RNF126 confers sensitivity to PARP inhibitors in triple-negative breast cancer cells","volume":"573","author":"Wu","year":"2021","journal-title":"Biochem Biophys Res Commun"},{"key":"B149","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1038\/s41419-025-07647-4","article-title":"USP28 promotes PARP inhibitor resistance by enhancing SOX9-mediated DNA damage repair in ovarian cancer","volume":"16","author":"Han","year":"2025","journal-title":"Cell Death Dis"},{"key":"B150","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2020.107985","article-title":"The ubiquitin ligase TRIP12 limits PARP1 trapping and constrains PARP inhibitor efficiency","volume":"32","author":"Gatti","year":"2020","journal-title":"Cell Rep"},{"key":"B151","doi-asserted-by":"publisher","first-page":"3726","DOI":"10.1038\/s41467-020-17127-2","article-title":"Combining PARP with ATR inhibition overcomes PARP inhibitor and platinum resistance in ovarian cancer models","volume":"11","author":"Kim","year":"2020","journal-title":"Nat Commun"},{"key":"B152","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.Ccr-22-2444","article-title":"Combination ATR (ceralasertib) and PARP (olaparib) inhibitor (CAPRI) trial in acquired PARP inhibitor-resistant homologous recombination-deficient ovarian cancer","volume":"29","author":"Wethington","year":"2023","journal-title":"Clin Cancer Research: Off J Am Assoc For Cancer Res"},{"key":"B153","doi-asserted-by":"publisher","first-page":"924","DOI":"10.1038\/s41419-024-07290-5","article-title":"Targeting TRAF6\/IRF3 axis to inhibit NF-\u03baB-p65 nuclear translocation enhances the chemosensitivity of 5-FU and reverses the proliferation of gastric cancer","volume":"15","author":"Chen","year":"2024","journal-title":"Cell Death Dis"},{"key":"B154","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0308496101","article-title":"Toll-like receptor 3-mediated activation of NF-kappaB and IRF3 diverges at Toll-IL-1 receptor domain-containing adapter inducing IFN-beta","volume":"101","author":"Jiang","year":"2004","journal-title":"PNAS"},{"key":"B155","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1038\/s41419-025-07621-0","article-title":"TMEM160 inhibits KEAP1 to suppress ferroptosis and induce chemoresistance in gastric cancer","volume":"16","author":"Huang","year":"2025","journal-title":"Cell Death Dis"},{"key":"B156","doi-asserted-by":"publisher","DOI":"10.1038\/s41418-020-00728-1","article-title":"Cellular degradation systems in ferroptosis","volume":"28","author":"Chen","year":"2021","journal-title":"Cell Death Differ"},{"key":"B157","doi-asserted-by":"publisher","DOI":"10.1016\/j.tranon.2025.102423","article-title":"GLI2-HRD1 axis facilitates 5-FU resistance in gastric cancer cells by regulating ubiquitination degradation of UCK2","volume":"58","author":"Xue","year":"2025","journal-title":"Transl Oncol"},{"key":"B158","doi-asserted-by":"publisher","DOI":"10.1002\/jcp.30260","article-title":"Emerging role of RNF2 in cancer: From bench to bedside","volume":"236","author":"Yan","year":"2021","journal-title":"J Cell Physiol"},{"key":"B159","doi-asserted-by":"publisher","DOI":"10.1016\/j.tranon.2025.102489","article-title":"TRIM26 as a dual regulator of ferroptosis and chemoresistance in gastric cancer through HSF1 ubiquitination and exosomal miR-24-3p signaling","volume":"60","author":"Al-Abbas","year":"2025","journal-title":"Transl Oncol"},{"key":"B160","doi-asserted-by":"publisher","DOI":"10.1016\/j.febslet.2010.05.033","article-title":"HECT ubiquitin ligase Smurf1 targets the tumor suppressor ING2 for ubiquitination and degradation","volume":"584","author":"Nie","year":"2010","journal-title":"FEBS Lett"},{"key":"B161","doi-asserted-by":"publisher","first-page":"15065","DOI":"10.1038\/nrdp.2015.65","article-title":"Colorectal cancer","volume":"1","author":"Kuipers","year":"2015","journal-title":"Nat Rev Dis Primers"},{"key":"B162","doi-asserted-by":"publisher","DOI":"10.1080\/15548627.2025.2477443","article-title":"HMBOX1 reverses autophagy mediated 5-fluorouracil resistance through promoting HACE1-induced ubiquitination and degradation of ATG5 in colorectal cancer","volume":"21","author":"Gao","year":"2025","journal-title":"Autophagy"},{"key":"B163","doi-asserted-by":"publisher","DOI":"10.1093\/carcin\/bgad040","article-title":"The ubiquitin E3 ligase MDM2 induces chemoresistance in colorectal cancer by degradation of ING3","volume":"44","author":"Zhang","year":"2023","journal-title":"Carcinogenesis"},{"key":"B164","doi-asserted-by":"publisher","DOI":"10.2147\/ott.S271855","article-title":"Overexpression of RNF126 promotes the development of colorectal cancer via enhancing p53 ubiquitination and degradation","volume":"13","author":"Wang","year":"2020","journal-title":"OncoTargets Ther"},{"key":"B165","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202301088","article-title":"Inhibition of CDK1 overcomes oxaliplatin resistance by regulating ACSL4-mediated ferroptosis in colorectal cancer","volume":"10","author":"Zeng","year":"2023","journal-title":"Adv Sci (Weinh)"},{"key":"B166","doi-asserted-by":"publisher","DOI":"10.1038\/s41388-023-02928-8","article-title":"The E3 ligase HUWE1 increases the sensitivity of CRC to oxaliplatin through TOMM20 degradation","volume":"43","author":"Lee","year":"2024","journal-title":"Oncogene"},{"key":"B167","doi-asserted-by":"publisher","DOI":"10.3390\/cells12010201","article-title":"The E3 ligase TRIM25 impairs apoptotic cell death in colon carcinoma cells via destabilization of caspase-7 mRNA: A possible role of hnRNPH1","volume":"12","author":"Nasrullah","year":"2023","journal-title":"Cells"},{"key":"B168","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1186\/s13045-022-01314-3","article-title":"Targeting p53-MDM2 interaction by small-molecule inhibitors: Learning from MDM2 inhibitors in clinical trials","volume":"15","author":"Zhu","year":"2022","journal-title":"J Hematol Oncol"},{"key":"B169","doi-asserted-by":"publisher","DOI":"10.3390\/molecules30010186","article-title":"Novel inhibitors for MDM2-MDM4 E3 ligase potently induce p53-indepedent apoptosis in drug-resistant leukemic cells","volume":"30","author":"Lama","year":"2025","journal-title":"Molecules (Basel Switzerland)"},{"key":"B170","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmech.2022.114334","article-title":"Small-molecule MDM2 inhibitors in clinical trials for cancer therapy","volume":"236","author":"Wang","year":"2022","journal-title":"Eur J Med Chem"},{"key":"B171","doi-asserted-by":"publisher","DOI":"10.1038\/s41375-020-0949-z","article-title":"MDM2 inhibition: An important step forward in cancer therapy","volume":"34","author":"Konopleva","year":"2020","journal-title":"Leukemia"},{"key":"B172","doi-asserted-by":"publisher","DOI":"10.1016\/j.jsps.2023.101790","article-title":"Advancements in MDM2 inhibition: Clinical and pre-clinical investigations of combination therapeutic regimens","volume":"31","author":"Alaseem","year":"2023","journal-title":"Saudi Pharm Journal: SPJ: Off Publ Saudi Pharm Soc"},{"key":"B173","doi-asserted-by":"publisher","first-page":"558","DOI":"10.3892\/ol.2021.12819","article-title":"Enhanced G1 arrest and apoptosis via MDM4\/MDM2 double knockdown and MEK inhibition in wild-type TP53 colon and gastric cancer cells with aberrant KRAS signaling","volume":"22","author":"Wang","year":"2021","journal-title":"Oncol Lett"},{"key":"B174","doi-asserted-by":"publisher","DOI":"10.1124\/pharmrev.123.001026","article-title":"MDM2 inhibitors for cancer therapy: The past, present, and future","volume":"76","author":"Wang","year":"2024","journal-title":"Pharmacol Rev"},{"key":"B175","doi-asserted-by":"publisher","DOI":"10.1016\/j.gendis.2024.101279","article-title":"MDM2 inhibitors in cancer immunotherapy: Current status and perspective","volume":"11","author":"Zeng","year":"2024","journal-title":"Genes Dis"},{"key":"B176","doi-asserted-by":"publisher","first-page":"1","DOI":"10.2147\/dddt.S286373","article-title":"Targeting protein neddylation to inactivate cullin-RING ligases by gossypol: A lucky hit or a new start","volume":"15","author":"Yu","year":"2021","journal-title":"Drug Des Dev Ther"},{"key":"B177","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2007328118","article-title":"Inhibitors of cullin-RING E3 ubiquitin ligase 4 with antitumor potential","volume":"118","author":"Wu","year":"2021","journal-title":"PNAS"},{"key":"B178","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1007\/978-981-15-1025-0_18","article-title":"Targeting protein neddylation for cancer therapy","volume":"1217","author":"Zhou","year":"2020","journal-title":"Adv Exp Med Biol"},{"key":"B179","doi-asserted-by":"publisher","DOI":"10.1016\/j.neo.2020.02.003","article-title":"Gossypol inhibits cullin neddylation by targeting SAG-CUL5 and RBX1-CUL1 complexes","volume":"22","author":"Yu","year":"2020","journal-title":"Neoplasia (New York NY)"},{"key":"B180","doi-asserted-by":"publisher","DOI":"10.3390\/cells9061332","article-title":"CUL4-DDB1-CRBN E3 ubiquitin ligase regulates proteostasis of ClC-2 chloride channels: Implication for aldosteronism and leukodystrophy","volume":"9","author":"Fu","year":"2020","journal-title":"Cells"},{"key":"B181","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jmedchem.1c00035","article-title":"Improvement of oral bioavailability of pyrazolo-pyridone inhibitors of the interaction of DCN1\/2 and UBE2M","volume":"64","author":"Kim","year":"2021","journal-title":"J Med Chem"},{"key":"B182","doi-asserted-by":"publisher","DOI":"10.1007\/978-981-15-1025-0_20","article-title":"Targeting DCN1-UBC12 protein-protein interaction for regulation of neddylation pathway","volume":"1217","author":"Zhou","year":"2020","journal-title":"Adv Exp Med Biol"},{"key":"B183","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2024.114802","article-title":"Hormone-mediated disassembly and inactivation of a plant E3 ubiquitin ligase complex","volume":"43","author":"Mart\u00ednez","year":"2024","journal-title":"Cell Rep"},{"key":"B184","doi-asserted-by":"publisher","first-page":"2621","DOI":"10.1038\/s41467-021-22924-4","article-title":"Selective inhibition of cullin 3 neddylation through covalent targeting DCN1 protects mice from acetaminophen-induced liver toxicity","volume":"12","author":"Zhou","year":"2021","journal-title":"Nat Commun"},{"key":"B185","doi-asserted-by":"publisher","first-page":"195","DOI":"10.33696\/Signaling.2.051","article-title":"Targeting cullin-RING E3 ubiquitin ligase 4 by small molecule modulators","volume":"2","author":"Wu","year":"2021","journal-title":"J Cell Signaling"},{"key":"B186","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2023.115814","article-title":"Suramin, a drug for the treatment of trypanosomiasis, reduces the prothrombotic and metastatic phenotypes of colorectal cancer cells by inhibiting hepsin","volume":"168","author":"Zaragoza-Huesca","year":"2023","journal-title":"Biomedicine Pharmacotherapy = Biomedecine Pharmacotherapie"},{"key":"B187","doi-asserted-by":"publisher","DOI":"10.3390\/biom15030372","article-title":"CSN-CRL complexes: New regulators of adipogenesis","volume":"15","author":"Dubiel","year":"2025","journal-title":"Biomolecules"},{"key":"B188","doi-asserted-by":"publisher","DOI":"10.4161\/cc.25591","article-title":"Targeting mitotic exit with hyperthermia or APC\/C inhibition to increase paclitaxel efficacy","volume":"12","author":"Giovinazzi","year":"2013","journal-title":"Cell Cycle (Georgetown Tex)"},{"key":"B189","doi-asserted-by":"publisher","DOI":"10.1080\/21655979.2021.2003927","article-title":"Apcin inhibits the growth and invasion of glioblastoma cells and improves glioma sensitivity to temozolomide","volume":"12","author":"Ding","year":"2021","journal-title":"Bioengineered"},{"key":"B190","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jmedchem.5c00416","article-title":"De novo-designed APC\/C inhibitors provide a rationale for targeting RING-type E3 ubiquitin ligases","volume":"68","author":"Ruiz-G\u00f3mez","year":"2025","journal-title":"J Med Chem"},{"key":"B191","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/s0305-7372(03)00081-1","article-title":"The proteasome: Structure, function, and role in the cell","author":"Adams","year":"2003","journal-title":"Cancer Treat Rev"},{"key":"B192","doi-asserted-by":"publisher","DOI":"10.1038\/nrclinonc.2016.206","article-title":"Proteasome inhibitors in cancer therapy","volume":"14","author":"Manasanch","year":"2017","journal-title":"Nat Rev Clin Oncol"},{"key":"B193","doi-asserted-by":"publisher","DOI":"10.1126\/science.1244917","article-title":"The myeloma drug lenalidomide promotes the cereblon-dependent destruction of Ikaros proteins","volume":"343","author":"Lu","year":"2014","journal-title":"Science"},{"key":"B194","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1038\/s41573-021-00371-6","article-title":"PROTAC targeted protein degraders: The past is prologue","volume":"21","author":"Bekes","year":"2022","journal-title":"Nat Rev Drug Discov"},{"key":"B195","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.ddtec.2019.01.002","article-title":"PROteolysis TArgeting Chimeras (PROTACs) - Past, present and future","volume":"31","author":"Pettersson","year":"2019","journal-title":"Drug Discov Today Technol"},{"key":"B196","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-pharmtox-010715-103507","article-title":"Targeted protein degradation by small molecules","volume":"57","author":"Bondeson","year":"2017","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"B197","doi-asserted-by":"publisher","DOI":"10.1038\/d41573-021-00052-4","article-title":"Targeted protein degraders crowd into the clinic","volume":"20","author":"Mullard","year":"2021","journal-title":"Nat Rev Drug Discov"},{"key":"B198","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.cell.2020.12.020","article-title":"The rise of molecular glues","volume":"184","author":"Schreiber","year":"2021","journal-title":"Cell"},{"key":"B199","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jmedchem.5c01229","article-title":"Isoquinolinone-naphthoquinone hybrids as potent PARP-1 inhibitors induce apoptosis in glioma via DNA damage and ROS generation","volume":"68","author":"Pathi","year":"2025","journal-title":"J Med Chem"},{"key":"B200","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2020007081","article-title":"Multiple cereblon genetic changes are associated with acquired resistance to lenalidomide or pomalidomide in multiple myeloma","volume":"137","author":"Gooding","year":"2021","journal-title":"Blood"},{"key":"B201","doi-asserted-by":"publisher","DOI":"10.1016\/j.gendis.2021.08.003","article-title":"Chaperone-assisted E3 ligase CHIP: A double agent in cancer","volume":"9","author":"Kumar","year":"2022","journal-title":"Genes Dis"},{"key":"B202","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccell.2014.09.013","article-title":"Tumor suppression by the Fbw7 ubiquitin ligase: mechanisms and opportunities","volume":"26","author":"Davis","year":"2014","journal-title":"Cancer Cell"},{"key":"B203","doi-asserted-by":"publisher","DOI":"10.1016\/j.febslet.2012.03.017","article-title":"Tumor suppressor functions of FBW7 in cancer development and progression","volume":"586","author":"Wang","year":"2012","journal-title":"FEBS Lett"},{"key":"B204","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2014.12.021","article-title":"RNF168 promotes noncanonical K27 ubiquitination to signal DNA damage","volume":"10","author":"Gatti","year":"2015","journal-title":"Cell Rep"},{"key":"B205","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbamcr.2024.119827","article-title":"E3 ubiquitin ligases and deubiquitinases in colorectal cancer: Emerging molecular insights and therapeutic opportunities","volume":"1871","author":"Kumar","year":"2024","journal-title":"Biochim Biophys Acta Mol Cell Res"},{"key":"B206","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1186\/s12943-018-0857-2","article-title":"FBXW7: a critical tumor suppressor of human cancers","volume":"17","author":"Yeh","year":"2018","journal-title":"Mol Cancer"},{"key":"B207","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbamcr.2025.120049","article-title":"CHIP modulates Wnt\/beta-catenin signalling in colorectal cancer through proteasomal degradation of DDX17","volume":"1872","author":"Kumar","year":"2025","journal-title":"Biochim Biophys Acta Mol Cell Res"},{"key":"B208","doi-asserted-by":"publisher","DOI":"10.1038\/s41573-019-0050-3","article-title":"Rethinking drug design in the artificial intelligence era","volume":"19","author":"Schneider","year":"2020","journal-title":"Nat Rev Drug Discov"},{"key":"B209","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-021-03819-2","article-title":"Highly accurate protein structure prediction with AlphaFold","volume":"596","author":"Jumper","year":"2021","journal-title":"Nature"},{"key":"B210","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1016\/j.molcel.2019.09.009","article-title":"AUTACs: Cargo-specific degraders using selective autophagy","volume":"76","author":"Takahashi","year":"2019","journal-title":"Mol Cell"},{"key":"B211","doi-asserted-by":"publisher","DOI":"10.1038\/s41573-019-0047-y","article-title":"Targeted protein degradation: expanding the toolbox","volume":"18","author":"Schapira","year":"2019","journal-title":"Nat Rev Drug Discov"}],"container-title":["Frontiers in Oncology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2026.1835284\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T14:07:38Z","timestamp":1787839658000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2026.1835284\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,27]]},"references-count":211,"alternative-id":["10.3389\/fonc.2026.1835284"],"URL":"https:\/\/doi.org\/10.3389\/fonc.2026.1835284","relation":{},"ISSN":["2234-943X"],"issn-type":[{"value":"2234-943X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,27]]},"article-number":"1835284"}}